Molecular diagnosis and treatment of multiple endocrine neoplasia type 2B in Ethnic Han Chinese.

CONCLUSION: The initial diagnosis of MEN 2B is relatively later, and diagnosed by non-endocrine components is extremely lower. Recognition of MEN 2B and its non-endocrine-related components is still the utmost requirement for a Chinese physician. Combined RET screening and serum calcitonin detection can facilitate early diagnosis. PMID: 32914730 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32914730?dopt=Abstract

Source: Endocrine, Metabolic and Immune Disorders Drug Targets - September 9, 2020 Category: Endocrinology Authors: Zhang ZW, Guo X, Qi XP Tags: Endocr Metab Immune Disord Drug Targets Source Type: research